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Papulopustular eruption (PPE) is an adverse reaction of the skin most commonly seen in cancer patients treated 
with EGFR inhibitors. Although PPE is distinct from folliculitis/acne by its clinical manifestations, the underlying 
mechanism is still undefined. We first investigated the histological difference between PPE and unrelated 
folliculitis. Abundant droplets accumulated within intraepidermal pustules in PPE, and were positive for 
adipophilin, suggestive of sebum-derived. In PPE, a number of cell infiltrates was found around the sebaceous 
glands, not around the infundibulum frequently found in folliculitis. Interestingly, histology from lesions at the 
earlier stage of PPE revealed sebaceous hypertrophy with positive staining for TNF-. These finding lead us to 
speculate that sebaceous gland might be the primary target of EGFR inhibitors and plays a major role in the onset 
of PPE. Next we studied the effects of EGFR inhibitor (cetuximab) on the biology of immortalized human 
sebaceous gland cell line, SZ95. Stimulation of SZ95 cells with cetuximab resulted in increase of the expression 
of various proinflammatory cytokines and sebocyte differentiation-related molecules, adipophilin and 
melanocortin-5 receptor. These results suggested that EGFR-inhibitors targeted sebocytes, which subsequently 
released proinflammatory cytokines and sebum. L-ascorbyl-2-phospate (APS) is an anti-oxidant and inhibitor of 
sebum secretion. APS suppressed the expression of IL-6, IL-8 and TNF- in cetuximab-treated SZ95 in a 
dose-dependent manner. These results indicate that APS would be therapeutically effective for the treatment of 
PPE induced by EGFR inhibitors. 
